Given what we know now, there is significant doubt as to the validity and utility of the prior data (Oz etc), given the way it was gathered. They need a complete reset. If they keep avoiding adhering to industry standard trial requirements with their trials in Oz, we have our answer. If they cant do it here of all places, at home, what makes them think they can do them in an environment they are not in the least bit familiar with. In retrospect the worst prep ever, and one based it seems on calculated avoidance. Hell my puny taste test panels I helped conduct in the dairy industry were blind. Wont be surprised if at some point FIL and other instos begin proceedings beginning with a request of a thorough audit of the prior data, which was the basis of the RAPs reputation, its principal marketing ploy and which was used to spruik RAP to all and sundry since it began its life as a listing on the ASX.
Yep, asking the hard questions now, I know. Lots to learn, a process that never ends
Conference Call Summary, page-372
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #